Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Demannose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TOP1 | P11387 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demannose SCHEMBL1334995 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Galactose SCHEMBL423422 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Demannose SCHEMBL29844979 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Galactose SCHEMBL31555927 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Demannose SCHEMBL3630269 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Galactose SCHEMBL30458008 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Demannose SCHEMBL29395609 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Demannose SCHEMBL13277644 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Demannose SCHEMBL8560244 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| Demannose SCHEMBL177710 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4341269-A1 | FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION | Olix US, Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-2019197510-A1 | GLYCO-ENGINEERED INTERLEUKIN-4 BASED ANTAGONISTS | JULIUS-MAXIMILIANS UNIVERSITÄT WÜRZBURG (DE) | 2019-10-17 | — | — | WO | disclosed |
| EP-3553078-A1 | GLYCO-ENGINEERED INTERLEUKIN-4 BASED ANTAGONISTS | Julius-Maximilians-Universität Würzburg (DE) | 2019-10-16 | — | — | EP | disclosed |